Abarca, Amgen Enter Outcomes-Based Agreement For Repatha® (evolocumab) First-of-its-kind agreement between Amgen and a standalone PBM

February 23, 2018

MIAMI, Feb. 22, 2018 /PRNewswire/ — Abarca, a pharmacy benefit manager that is disrupting the industry with smarter technology and innovative strategies, today announced it has signed an outcomes-based contract with Amgen for the cholesterol-lowering drug, Repatha® (evolocumab). This agreement is the first of its kind involving Amgen’s Repatha and a standalone PBM.   “In […]

Idaho Blue Cross Jumps Into Controversial Market For Plans That Bypass ACA Rules

February 15, 2018

That didn’t take long.   It’s barely been two weeks since Idaho regulators said they would allow the sale of health insurance that does not meet all of the Affordable Care Act’s requirements — a controversial step some experts said would likely draw legal scrutiny and, potentially, federal fines for any insurer that jumped in. […]

AVEO Announces EUSA Pharma Granted Positive NICE Recommendation for FOTIVDA® (tivozanib) as First Line Treatment for Advanced Renal Cell Carcinoma

February 12, 2018

CAMBRIDGE, Mass. – February 12, 2018 – AVEO Oncology (NASDAQ:AVEO) today announced that the United Kingdom’s National Institute for Health and Care Excellence (NICE) has published a Final Appraisal Determination (FAD) recommending FOTIVDA®(tivozanib) for the first line treatment of adult patients with advanced renal cell carcinoma (aRCC). In the European Union, Norway and Iceland, tivozanib […]

Two Labs Acquires MKO Global Partners

February 8, 2018

FOR IMMEDIATE RELEASE Media Contact: Alexis Marina 330-519-6892   Two Labs Acquires MKO Global Partners Company expands presence in the pharma consulting space with the addition of pricing and payer strategy services COLUMBUS, Ohio (February 8, 2018) – Two Labs, an industry-leading pharma and life science services company, today announced that it has acquired MKO […]

Acerus Pharma’s NATESTO® to Be Listed for Public Reimbursement in Quebec, Building on Strong 28% Increase in Natesto’s Canadian Prescriptions in Q4 2017

February 2, 2018

TORONTO–(BUSINESS WIRE)–Acerus Pharmaceuticals Corporation (TSX:ASP) (“Acerus” or the “Company”) today announced that it has received notice from Quebec’s National Institute for Excellence in Health and Social Services (INESSS) of a positive recommendation to the Health Minister for the inclusion of NATESTO® on the list of medications of the Régie de l’assurance maladie du Québec. This […]

Amazon, Berkshire Hathaway and J.P. Morgan Are Forming a Non-Profit Health Care Company

February 1, 2018

Amazon, Berkshire Hathaway, and J.P. Morgan Chase are forming a not-for-profit health care venture to lower health care costs for their U.S. employees, the companies announced Tuesday morning, sparking a slide in the shares of a host of health care-related companies. The initial focus of the independent company will be on technology that will provide […]

BIOGEN Optimistic for Rapid and Broad Patient Access Following Invitation to Submit SPINRAZA® (nusinersen)▼ to National Institute for Health and Care Excellence (NICE) for Single Technology Appraisal (STA)

January 22, 2018

MAIDENHEAD, England, January 22, 2018 /PRNewswire/ —   Managed Access Agreement to be developed in parallel to urgently provide effective new treatment to patients in England   The National Institute for Health and Care Excellence (NICE) has formally invited Biogen to submit SPINRAZA (nusinersen), the first and only disease-modifying treatment for 5q spinal muscular atrophy […]

RedHill Biopharma and Express Scripts Subsidiary Inside Rx Add EnteraGam® to Savings Program for Uninsured or Underinsured Patients

January 17, 2018

TEL-AVIV, Israel and RALEIGH, N.C., Jan. 17, 2018 (GLOBE NEWSWIRE) — RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on late clinical-stage development and commercialization of proprietary drugs for gastrointestinal diseases and cancer, today announced that EnteraGam® (serum-derived bovine immunoglobulin/protein isolate, SBI)1 was added to the […]

Alnylam Expands Alnylam Act™ Program to Include No-Charge Third-Party Genetic Testing and Counseling for People at Risk for Acute Hepatic Porphyrias

January 5, 2018

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced it has expanded the Alnylam Act™ program to include no-charge, third-party genetic testing and counseling for individuals who may carry a gene mutation known to be associated with acute hepatic porphyrias (AHPs), a family of ultra-rare, often misdiagnosed genetic diseases. AHPs […]

NHS should fund GSK’s £526,000 “bubble baby” drug – NICE

January 4, 2018

NICE has recommended that the NHS should fund GlaxoSmithKline’s Strimvelis gene therapy for the extremely rare immune deficiency condition known as ‘bubble baby syndrome’.   Costing €594,000 ($717,700 USD) Strimvelis is the most expensive therapy cleared by NICE, but the drug is administered in a single curative dose for adenosine deaminase deficiency (ADA-SCID).   The […]

The California Co-Pay Conundrum

January 2, 2018

TrialCard Addresses AB 265 On October 9, 2017, California Governor Jerry Brown signed AB 265 into law. This landmark piece of legislation modified the California Health and Safety Code to prohibit the “offering” of any discount, product voucher, or other out-of-pocket cost reduction tool by drug manufacturers when there is an FDA-approved therapeutic equivalent. As […]

Four major questions about the proposed CVS-Aetna merger

December 7, 2017

The largest healthcare M&A transaction of the year — CVS Health’s bid to buy Aetna for $69 billion — is the kind of deal that can upend an industry. At the very least, it will make plenty of waves.   What kind of waves, however, remains to be seen. The deal reflects a number of […]

As Health Care Changes, Insurers, Hospitals and Drugstores Team Up

November 30, 2017

They seem like odd couples: Aetna, one of the nation’s largest health insurers, is in talks to combine with CVS Health, which manages pharmacy benefits. The Cleveland Clinic, a highly regarded health system, joined forces with an insurance start-up, Oscar Health, to offer individuals a health plan in Ohio.   Aetna also has new partnerships […]

In Big Win for JDRF’s Coverage2Control Campaign, Anthem Decides to Cover Artificial Pancreas Systems

November 22, 2017

— America’s 25 largest health insurers now all cover this breakthrough diabetes technology NEW YORK, November 17, 2017 – JDRF, the leading global organization funding type 1 diabetes (T1D) research, today announced that its Coverage2Control campaign swayed Anthem, America’s second-largest health insurance company, to cover artificial pancreas (AP) systems. Anthem changed its policy after engaging […]

Cardinal Health Launches Opioid Action Program to Support Drug Abuse Prevention and Education in Appalachia

November 16, 2017

Company to Collaborate with Key Partners across Ohio, Kentucky, Tennessee and West Virginia DUBLIN, Ohio, Nov. 16, 2017 /PRNewswire/ — Cardinal Health (NYSE: CAH) today launched its new Opioid Action Program, aimed at helping communities in four of the nation’s hardest-hit states across Appalachia combat the opioid epidemic. The pilot program will deliver much needed […]

US Dept. of Veterans Affairs Renews and Expands Cancer Testing Contract with Personal Genome Diagnostics

November 13, 2017

–-PGDx’s Pan-Cancer Profiling Panels with MSI Testing for Immuno-Oncology Applications Are Now Available Nationwide to Cancer Patients Treated at the VA–                                                                                                   –PGDx’s CancerSELECTTM 125 Offers Comprehensive Tissue-Based Tumor Profiling and Its PlasmaSELECTTM 64 Is First Liquid Biopsy Assay Available to Patients at VA Facilities— BALTIMORE, MD –Personal Genome Diagnostics Inc. (PGDx) today announced the renewal […]

Verma Outlines Vision for Medicaid, Announces Historic Steps Taken to Improve the Program

November 9, 2017

Today, Centers for Medicare & Medicaid Services (CMS) Administrator Seema Verma discussed her vision for the future of Medicaid and unveiled new CMS policies that encourage states to propose innovative Medicaid reforms, reduce federal regulatory burdens, increase efficiency, and promote transparency and accountability during a plenary session at the National Association of Medicaid Directors (NAMD) […]

Surescripts Joins Epic, CVS to Deliver Drug Pricing Info in EHRs

November 9, 2017

Surescripts announced an effort to increase transparency around prescription drug benefits and pricing. Working with EHR vendors and pharmacy benefit managers, Surescripts will provide real-time patient-specific benefit and price information to providers at the point of care. Once integrated with the EHR, patients and doctors will also be able to see information and pricing on […]